How much is Generate:Biomedicines worth in 2026?

Generate:Biomedicines has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Generate:Biomedicines raised?

Generate:Biomedicines has raised $693.0M in total funding across 2 funding rounds.

Generate:Biomedicines

BiotechnologyWebsite

Generate:Biomedicines valuation and funding history | Last updated: November 26, 2024 | 2 funding rounds

Current Valuation

N/A

As of November 26, 2024

Total Funding Raised

$693.0M

Across 2 rounds

Last Round

Later Stage VC

$273.0M

Last Funding

Nov 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 6, 2023	Later Stage VC (Series C)	$273.0M	N/A	-
November 18, 2021	Early Stage VC (Series B)	$370.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Generate:Biomedicines is currently valued at N/A as of November 26, 2024. The company has raised a total of $693.0M in funding across 2 funding rounds.

Track Generate:Biomedicines Valuation Updates

Get notified when Generate:Biomedicines raises new funding or valuation changes

Explore More Data

Detailed analysis for Generate:Biomedicines

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Generate:Biomedicines's valuation history, funding rounds, and growth metrics.

No credit card required

What is Generate:Biomedicines Worth in 2026?

Generate:Biomedicines is a leading private company in the Biotechnology sector. Track Generate:Biomedicines's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Generate:Biomedicines Valuation is Determined

Private company valuations like Generate:Biomedicines's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.